News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
295 Results
Type
Article (15)
Press Release (280)
Section
Business (66)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
Best Places to Work (40)
Cancer (1)
Clinical research (65)
COVID-19 (5)
Data (2)
Diagnostics (5)
Earnings (32)
Events (72)
FDA (14)
Government (6)
Healthcare (6)
Infectious disease (5)
IPO (11)
Job creations (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2025 (6)
Pancreatic cancer (1)
Patents (1)
People (16)
Phase I (49)
Phase II (39)
Phase III (13)
Pipeline (2)
Preclinical (17)
Real estate (1)
Regulatory (15)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (14)
2025 (14)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (1)
Europe (3)
Texas (15)
United States (15)
295 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
July 10, 2025
·
8 min read
Press Releases
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML
June 19, 2025
·
7 min read
Press Releases
Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
·
13 min read
Press Releases
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
May 12, 2025
·
8 min read
Press Releases
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
May 7, 2025
·
6 min read
Press Releases
Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents
May 5, 2025
·
5 min read
Press Releases
Moleculin to Report First Quarter 2025 Financial Results on May 13, 2025 and Host Conference Call and Webcast
May 7, 2025
·
4 min read
Press Releases
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
April 1, 2025
·
6 min read
Press Releases
Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 17, 2025
·
4 min read
Press Releases
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
April 30, 2025
·
6 min read
1 of 30
Next
